Fabrizio Chiodo

fabrizio.chiodo@icb.cnr.it

Institute
Institute for Biomolecular Chemistry Pozzuoli (NA)
https://www.icb.cnr.it/

• Molecular Basis of Siglec‑7 Recognition by Neisseria meningitidis Serogroup Y CPS: Implications for Immune Evasion. 2025 JACS Au. 5(5):2257-2269 Carbohydrate-Mediated Interactions Between Chloroviruses and the Immune System. 2024 Communications Biology 7, 1670

• Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial, 2022, The Lancet Respiratory Medicine, 10, 785-795

• Molecular aspects concerning the use of SARS-CoV-2 Receptor Binding Domain as target for preventive vaccines. 2021, ACS Central Science, 7, 757-767

• Synthetic, zwitterionic Sp1-oligosaccharides adopt a helical structure crucial for antibody interaction. 2019, ACS Central Science, 5, 1407

• Molecular Basis of Siglec‑7 Recognition by Neisseria meningitidis Serogroup Y CPS: Implications for Immune Evasion. 2025 JACS Au. 5(5):2257-2269 Carbohydrate-Mediated Interactions Between Chloroviruses and the Immune System. 2024 Communications Biology 7, 1670

• Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial, 2022, The Lancet Respiratory Medicine, 10, 785-795

• Molecular aspects concerning the use of SARS-CoV-2 Receptor Binding Domain as target for preventive vaccines. 2021, ACS Central Science, 7, 757-767

• Synthetic, zwitterionic Sp1-oligosaccharides adopt a helical structure crucial for antibody interaction. 2019, ACS Central Science, 5, 1407

Expert for the European Medicines Agency